Brokers Offer Predictions for Agilon Health FY2025 Earnings

Agilon Health, Inc. (NYSE:AGLFree Report) – Research analysts at Leerink Partnrs cut their FY2025 earnings estimates for Agilon Health in a research report issued to clients and investors on Tuesday, November 4th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of ($0.79) per share for the year, down from their prior estimate of ($0.70). The consensus estimate for Agilon Health’s current full-year earnings is ($0.59) per share. Leerink Partnrs also issued estimates for Agilon Health’s Q1 2026 earnings at $0.02 EPS, Q2 2026 earnings at ($0.15) EPS, FY2026 earnings at ($0.35) EPS, FY2027 earnings at ($0.33) EPS, FY2028 earnings at ($0.28) EPS and FY2029 earnings at ($0.13) EPS.

Agilon Health (NYSE:AGLGet Free Report) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.18) by ($0.09). The business had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Agilon Health had a negative net margin of 5.24% and a negative return on equity of 75.92%. Agilon Health has set its FY 2025 guidance at EPS.

Several other analysts have also recently weighed in on AGL. Wells Fargo & Company reduced their target price on shares of Agilon Health from $1.50 to $1.00 and set an “overweight” rating on the stock in a report on Wednesday. Robert W. Baird dropped their target price on Agilon Health from $5.00 to $1.00 and set a “neutral” rating on the stock in a report on Thursday, August 14th. Jefferies Financial Group cut their price target on Agilon Health from $2.40 to $1.10 and set a “hold” rating on the stock in a research note on Friday, August 15th. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $1.40 price objective (down from $4.00) on shares of Agilon Health in a research report on Wednesday, August 20th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Agilon Health currently has an average rating of “Hold” and a consensus price target of $2.73.

View Our Latest Report on Agilon Health

Agilon Health Price Performance

AGL opened at $0.69 on Friday. The business has a fifty day moving average price of $1.04 and a 200 day moving average price of $1.85. Agilon Health has a 12 month low of $0.69 and a 12 month high of $6.08. The stock has a market capitalization of $287.86 million, a price-to-earnings ratio of -0.93 and a beta of 0.05.

Hedge Funds Weigh In On Agilon Health

Institutional investors have recently modified their holdings of the business. Amundi lifted its position in Agilon Health by 49.2% during the 1st quarter. Amundi now owns 1,484,709 shares of the company’s stock worth $5,939,000 after acquiring an additional 489,414 shares during the period. Caxton Associates LLP acquired a new stake in shares of Agilon Health during the first quarter worth $1,529,000. Nisa Investment Advisors LLC grew its position in Agilon Health by 244.9% in the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock valued at $41,000 after buying an additional 6,783 shares during the last quarter. Russell Investments Group Ltd. increased its stake in Agilon Health by 196.1% in the 1st quarter. Russell Investments Group Ltd. now owns 107,024 shares of the company’s stock valued at $463,000 after buying an additional 70,883 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its position in Agilon Health by 8.8% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 4,939,576 shares of the company’s stock worth $21,388,000 after buying an additional 398,027 shares during the last quarter.

About Agilon Health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Earnings History and Estimates for Agilon Health (NYSE:AGL)

Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.